Risk factor of hyperglycemia with enteral nutrition in non diabetic patients in clinic universitary hospital

2021 ◽  
Vol 46 ◽  
pp. S629-S630
Author(s):  
E. Delgado Garcia ◽  
J.J. Lopez Gomez ◽  
B. Torres Torres ◽  
E. Gomez Hoyos ◽  
C. Serrna Valles ◽  
...  
Keyword(s):  
Risk Factor ◽  
Enteral Nutrition ◽  
Diabetic Patients

scholarly journals Influence of Hyperglycemia Associated with Enteral Nutrition on Mortality in Patients with Stroke

Nutrients ◽  
2019 ◽  
Vol 11 (5) ◽  
pp. 996 ◽  
Author(s):  
López-Gómez ◽  
Delgado-García ◽  
Coto-García ◽  
Torres-Torres ◽  
Gómez-Hoyos ◽  
...  
Keyword(s):  
Multivariate Analysis ◽  
Risk Factor ◽  
Enteral Nutrition ◽  
Observational Study ◽  
Independent Risk Factor ◽  
Oral Feeding ◽  
Diabetic Patients ◽  
A Value ◽  
Longitudinal Observational Study ◽  
Lower Recovery

Objectives: To evaluate in patients admitted for stroke: (1) The frequency of hyperglycaemia associated with enteral nutrition (EN). (2) The risk of morbidity and mortality associated with the development of this type of hyperglycaemia. Methods: A longitudinal observational study was conducted in 115 non-diabetic patients admitted for stroke with EN. Age, functional capacity (Rankin scale), and blood plasma glucose (BPG) were recorded. Hyperglycaemia was considered as: a value higher than 126 mg/dL before the EN and/or a value higher than 150 mg/dL after a week of enteral nutrition. According to this, three groups were differentiated: HyperES: Those who had hyperglycemia before the beginning of the EN (33% patients); NoHyper: those who did not have hyperglycemia before or after (47.8% patients); and HyperEN: Those who did not have hyperglycemia before but suffered it after the beginning of the EN (19.1% patients). Results: The age was 72.72 (15.32) years. A higher rate of mortality was observed in the HyperEN group 45.50%, than HyperES 15.80% or NoHyper: 10.90%). A lower recovery of the oral feeding was observed in those patients of the HyperEN group 27.30%, than HyperES: 42.10% or NoHyper: 61.80%). In the multivariate analysis adjusting for age, sex, and Rankin scale the development of hyperglycemia in those who did not have it at the beginning (HyperEN) was an independent risk factor for non-recovery of the oral feeding (OR: 4.21 (1.20–14.79), p = 0.02); and mortality adjusted for age, sex and Rankin scale (OR: 6.83 (1.76–26.47), p < 0.01). Conclusions: In non-diabetic patients admitted for stroke with EN, the development of hyperglycaemia in relation to enteral nutrition supposes an independent risk factor for mortality and for the non-recovery of the oral feeding.

scholarly journals Type-2 Diabetes as a Risk Factor for Severe COVID-19 Infection

2021 ◽  
Vol 9 (6) ◽  
pp. 1211
Author(s):  
Mahnaz Norouzi ◽  
Shaghayegh Norouzi ◽  
Alistaire Ruggiero ◽  
Mohammad S. Khan ◽  
Stephen Myers ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Risk Factor ◽  
Inflammatory Responses ◽  
Significant Risk ◽  
Significant Risk Factor ◽  
Diabetic Patients ◽  
Angiotensin Converting Enzyme 2 ◽  
Immune System Dysfunction ◽  
Current Outbreak

The current outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), termed coronavirus disease 2019 (COVID-19), has generated a notable challenge for diabetic patients. Overall, people with diabetes have a higher risk of developing different infectious diseases and demonstrate increased mortality. Type 2 diabetes mellitus (T2DM) is a significant risk factor for COVID-19 progression and its severity, poor prognosis, and increased mortality. How diabetes contributes to COVID-19 severity is unclear; however, it may be correlated with the effects of hyperglycemia on systemic inflammatory responses and immune system dysfunction. Using the envelope spike glycoprotein SARS-CoV-2, COVID-19 binds to angiotensin-converting enzyme 2 (ACE2) receptors, a key protein expressed in metabolic organs and tissues such as pancreatic islets. Therefore, it has been suggested that diabetic patients are more susceptible to severe SARS-CoV-2 infections, as glucose metabolism impairments complicate the pathophysiology of COVID-19 disease in these patients. In this review, we provide insight into the COVID-19 disease complications relevant to diabetes and try to focus on the present data and growing concepts surrounding SARS-CoV-2 infections in T2DM patients.

Alteration in the temporal organisation of insulin secretion in diabetic patients under continuous enteral nutrition

1990 ◽  
Vol 9 ◽  
pp. 68
Author(s):  
G. Brandenberger ◽  
C. Simon ◽  
M. Follenius ◽  
J.L. Schlienger ◽  
J.M. Kahn
Keyword(s):  
Insulin Secretion ◽  
Enteral Nutrition ◽  
Diabetic Patients ◽  
Temporal Organisation

Cardiovascular events in patients with type 2 diabetes

2002 ◽  
Vol 2 (1_suppl) ◽  
pp. S4-S8
Author(s):  
Erland Erdmann
Keyword(s):  
Risk Factors ◽  
Insulin Resistance ◽  
Type 2 Diabetes ◽  
Risk Factor ◽  
Adverse Effects ◽  
Cardiovascular Events ◽  
Left Ventricular ◽  
Diabetic Patients ◽  
Increased Risk

Diabetes is a common risk factor for cardiovascular disease. Coronary heart disease and left ventricular dysfunction are more common in diabetic patients than in non-diabetic patients, and diabetic patients benefit less from revascularisation procedures. This increased risk can only partly be explained by the adverse effects of diabetes on established risk factors; hence, a substantial part of the excess risk must be attributable to direct effects of hyperglycaemia and diabetes. In type 2 diabetes, hyperinsulinaemia, insulin resistance and hyperglycaemia have a number of potential adverse effects, including effects on endothelial function and coagulation. Risk factor modification has been shown to reduce the occurrence of cardiovascular events in patients with diabetes; indeed, diabetic patients appear to benefit more in absolute terms than non-diabetic patients. There is thus a strong case for intensive treatment of risk factors, including insulin resistance and hyperglycaemia, in patients with type 2 diabetes.

scholarly journals Digital Subtraction Angiographic Pattern of Extracranial and Intracranial Atherosclerotic Arterial Stenosis among Ischemic Stroke Patients

2017 ◽  
Vol 33 (2) ◽  
pp. 89-95
Author(s):  
Md Alamgir Hossain ◽  
Hasan Zahidur Rahman ◽  
- Md Shahidullah ◽  
Md Rafiqul Islam ◽  
MA Hannan ◽  
...  
Keyword(s):  
Risk Factor ◽  
Ischemic Stroke ◽  
Adult Population ◽  
Intracranial Stenosis ◽  
Arterial Stenosis ◽  
P Value ◽  
Diabetic Patients ◽  
Atherosclerotic Stenosis ◽  
Extracranial Stenosis ◽  
Stenotic Segment

Background: Stroke is the second leading cause of death in adult population throughout the world and is the most common cause of severe adult physical disability. Atherosclerotic stenosis is one of the predominant cause of ischemic stroke. The aim of this study was to evaluate the type, number and severity of intracranial and extracranial atherosclerotic stenosis and its association with different risk factors. Methods: This prospective observational study was conducted in the Department of Neurology, BSMMU, Dhaka, from July 2017 to August 2018. Only patients having significant (≥50%) symptomatic stenosis were included in this study. Results: In total 42 cases, 25 patients had extracranial stenosis, 13 patients had intracranial stenosis and 4 patients had both intracranial and extracranial stenosis. Overall 17 (40.47%) patients have intracranial involvement and 29 (69.04%) patients had extracranial involvement. The most commonly involved intracranial stenotic segment was MCA, present in 8 (32%) out of 25 intracranial segments followed by ICA 7 (28%) and intracranial vertebral artery 4(16%). Most commonly involved extracranial stenotic segment was ICA, present in 37 (77.08%) out of 48 extracranial segments. Diabetes was found to be the most common risk factor of intracranial stenosis (p value 0.022) while hypercholesterolemia was the major risk factor for severe (≥70%) stenosis. Conclusion: Extracranial arterial stenosis is more common than intracranial arterial stenosis. Anterior circulation stenosis is more common than posterior circulation stenosis. Intracranial stenosis is more prevalent in diabetic patients. Hypercholesterolemiaismore commonly seen in severe (e”70%) stenosis. Bangladesh Journal of Neuroscience 2017; Vol. 33 (2): 89-95

scholarly journals High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes

2020 ◽  
Author(s):  
Stefano Ciardullo ◽  
Tommaso Monti ◽  
Gianluca Perseghin
Keyword(s):  
Type 2 Diabetes ◽  
African American ◽  
Risk Factor ◽  
Transient Elastography ◽  
Liver Steatosis ◽  
Liver Stiffness ◽  
Diabetic Patients ◽  
Advanced Fibrosis ◽  
American Ethnicity

<b>Objective:</b> Type 2 diabetes mellitus (T2DM) is an important risk factor for the progression of metabolic liver disease to advanced fibrosis. Here, we provide an estimate of the prevalence of steatosis and fibrosis in US adults with T2DM based on transient elastography (TE) and identify factors associated with these conditions. <p><b>Research Design and Methods: </b>This is a cross-sectional study of US adults with T2DM participating in the 2017-2018 cycle of the National Health and Nutrition Examination Survey who were evaluated by TE. Hepatic steatosis and fibrosis were diagnosed by the median value of Controlled Attenuation Parameter (CAP) and Liver Stiffness Measurement (LSM), respectively.</p> <p><b>Results:</b> Among the 825 patients with reliable TE exams, 484 (53.7%) were assessed using the M probe and 341 (46.3%) using the XL probe. Liver steatosis (CAP≥274 dB/m), advanced fibrosis (LSM≥9.7 Kpa) and cirrhosis (LSM≥13.6 Kpa) were present in 73.8% (95% CI 68.5%-78.5%), 15.4% (95% CI 12.2%-19.0%) and 7.7% (95% CI 4.8%-11.9%) of patients, respectively. Mean age of patients with advanced fibrosis and cirrhosis was 63.7 ± 2.2 years and 57.8 ± 1.6 years, respectively. In the multivariable logistic regression model, body mass index (BMI), non-African American ethnicity and alanine aminotransferase levels were independent predictors of steatosis, while BMI, non-African American ethnicity, aspartate aminotransferase and gamma-glutamyltranspeptidase levels were independent predictors of advanced fibrosis.</p> <p><b>Conclusions:</b> Prevalence of both liver steatosis and fibrosis are high in patients with T2DM from the US and obesity is a major risk factor. Our results support the screening of these conditions among diabetic patients.</p>

scholarly journals Serum High Lipoprotein(a) Levels in Patients with Type 2 Diabetes May Be an Independent Risk Factor for Hypertension

2021 ◽  
Vol 2 (2) ◽  
Author(s):  
Lingfen Zeng ◽  
Jieming Sun ◽  
Ming Cui
Keyword(s):  
Blood Pressure ◽  
Type 2 Diabetes ◽  
Risk Factor ◽  
Independent Risk Factor ◽  
Glycosylated Hemoglobin ◽  
Serum Triglyceride ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Lipoprotein A

Objective — To investigate whether serum lipoprotein(a) [Lp(a)] is an independent risk factor for abnormal blood pressure in patients with type 2 diabetes mellitus. Method — Analyzed data collected from diabetes patients and epidemiological survey from January 1,2020 to May 01,2021, with hypertension as a dependent variable, metabolic index such as glycosylated hemoglobin, serum total cholesterol, serum triglyceride and Lp(a) were independent variables, established logistic regression equation, analyze the influence of their variables on dependent variables. Results — The OR value of Lp(a) is 1.020, 95% confidence intervals (1.006, 1.035), p 0.006; The OR value of age is 1.073, 95% confidence interval (1.028, 1.119); and OR of the remaining parameters were tested no statistically different, p>0.05. Conclusions — The abnormal elevated Lp(a) level in the serum of type 2 diabetic patients may be related to the occurrence of hypertension. For patients with high Lp(a), Monitoring blood pressure may help to better detect and diagnose hypertension. At the same time, it is suggested that reducing serum Lp(a) level may reduce the risk of hypertension.

scholarly journals Prevalence of Diastolic Dysfunction in Non Diabetic Patients of Metabolic Syndrome

2021 ◽  
Author(s):  
Kaushiki Kirty ◽  
Prabha Adhikari
Keyword(s):  
Metabolic Syndrome ◽  
Risk Factor ◽  
Diastolic Dysfunction ◽  
Strong Correlation ◽  
Past History ◽  
Diabetic Patients ◽  
Short Term ◽  
The Metabolic Syndrome ◽  
History Of

Abstract Background :The purpose of the present study was to study the prevalence of metabolic syndrome in non diabetic patients of metabolic syndrome Materials and Methods: 100 patients of non diabetic metabolic syndrome were screened using 2-D Echocardiogram.Results: 34% of non diabetic patients of metabolic syndrome had diastolic dysfunction, with no association found between the components of metabolic syndrome and diastolic dysfunction. There was a strong correlation between a past history of hypertension and dyslipidemia with diastolic dysfunction.Conclusion: Our findings suggest that long standing metabolic syndrome is a risk factor for diastolic dysfunction, rather than short term elevation of the metabolic syndrome parameters. Also it is likely that Diabetes and Prediabetes itself is responsible for most of the diastolic dysfunction that is seen in metabolic syndrome

Sign in / Sign up

Export Citation Format

Share Document